Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Alphabet Inc.
A year after COVID-19 first turned the world upside down, executives across the biopharma industry consider what 2021 holds in store. The impact of the pandemic will have profound and long-lasting implications for a sector that has been at the heart of responding to the global health challenge.
Four device-related close-out letters were released by FDA in June.
The Netherlands-based biomaterials start-up intends to expand its platform's reach through strategic partnerships and tuck-in acquisitions.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.
- Digital Health
- Other Names / Subsidiaries
- Google Life Sciences
- Verily Life Sciences LLC